Dublin, Oct. 06, 2016 -- Research and Markets has announced the addition of the "Tangential Flow Filtration Market Product (Cassettes, Cartridges), Membrane Material (Polyethersulfone, Regenerated Cellulose), Technology (Ultrafiltration, Microfiltration), Pore Size (Ultrafilters), Application (Bioprocess) Global Forecast to 2021" report to their offering.
The tangential flow filtration market is projected to reach USD 1,005.0 million by 2021 USD 554.7 million in 2016, growing at a CAGR of 12.6% during the forecast period (2016-2021)
Growth in the biopharmaceutical industry, growth in the adoption of single-use technologies, and advantages of tangential flow filtration over normal flow filtration will boost the growth of the tangential flow filtration market.
In this report, the tangential flow filtration market is broadly segmented on the basis of product, membrane material, technology, pore size/MWCO, applications, and region. However, stringent government regulations for validation of filtration processes are restraining the growth of the tangential flow filtration market.
The North America is expected to account for the largest share of the tangential flow filtration market in 2016. Europe is the second-largest source for tangential flow filtration market; this regional market is driven by the availability of R&D funds in tangential flow filtration. Asia-Pacific region is estimated to be the fastest growing region in the tangential flow filtration market during the forecast period due to the increasing adoption of tangential flow filtration in this region.
New product launches is the dominant strategy adopted by key industry participants in the tangential flow filtration market to increase their market share and cater to unmet needs.
Major players in the market include Danaher Corporation (U.S.), Merck Millipore (U.S.), Sartorius Stedim Biotech S.A. (France), Parker Hannifin Corporation (U.S.), GE Healthcare (U.S.).
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Global Tangential Flow Filtration Market Overview
6 Global Market, By Product
7 Global Market, By Technology
8 Global Market, By Membrane Material
9 Global Market, By Pore Size/ Molecular Weight Cut-Off
10 Global Market, By Application
11 Global Market, By Region
12 Competitive Landscape
13 Company Profiles
- Alfa Laval AB
- Danaher Corporation
- GE Healthcare
- Koch Membrane Systems, Inc.
- Merck Millipore
- Novasep
- Parker Hannifin Corporation
- Pendotech
- Sartorius Stedim Biotech S.A.
- Spectrum Laboratories, Inc.
For more information about this report visit http://www.researchandmarkets.com/research/7x9lbt/tangential_flow
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



